Although we could still see another small dip or two before things get exciting again, it looks like we may have reached bottom, IMO, according to the charts. This PPS is where we were at through almost all of April, before the rally started.
On L2 there was a big block of shares at .2375, so I had to take advantage of it, since there's been very little shares available at cheap prices lately. There's still some left as of right now, so it's a good time to load up for you "sideliners!"
Watched a video yesterday..it may have been on yahoo...they were talking about the 2nd half (2H) of '13 and specifically biotechs.
They began talking about Merck and Bristol Meyers Squibb and PD-1 excitement at ASCO. The person they interviewed said that PD-1, if it worked on all cancers in the body systemically, would be a 5 to 10 BILLION dollar result.
He may have meant Merck or Bristol, but considering ONCS's PD-1 agreement with Old Dominion and the divide between their current valutaion and 5-10 BILLION, the excitement with immunopulse could just be an appetizer.